Strategic partnerships Hobbs Medical recently announced a strategic partnership with mBIOTA Labs to improve access to accurate SIBO diagnosis and evidence-based management solutions. This presents an opportunity to offer complementary endoscopy accessories, enhanced clinical workflow tools, and bundled solutions that align with SIBO diagnostic pathways.

New product launch The company launched the CleanCapture Aspiration Catheter at ACG 2025, signaling an active product development pipeline and open demand for innovative endoscopy accessories. Sales opportunities exist in cross-selling updated or related precision instruments, disposables, and training for adoption.

Growth focus With revenue in the lower mid-range and a history of rapid development and customization, Hobbs Medical seeks hospital systems, medical universities, ambulatory centers, and veterinary facilities that require tailored endoscopy accessories. Target institutions with high-volume GI and pulmonary procedures for premium, fast-turnaround solutions.

Leadership and stability Privately held, Hispanic-owned with internal leadership driven by the Ortega family, including board involvement by Alberto Ortega’s children and ongoing internal promotion. This suggests a stable, long-term partner capable of collaborative product development, pilot programs, and regional expansion initiatives.

Expanding ecosystem Recent announcement of a strategic partnership plus ongoing events presence indicates Hobbs Medical is actively expanding its ecosystem. Sales approaches could emphasize collaboration on prototyping, contract manufacturing, and compliant accessories for regulated markets to attract larger healthcare networks seeking vetted suppliers.